Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Cell and Gene Therapy for Cardiac Repair"
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: closed (20 April 2023) | Viewed by 5881
Special Issue Editor
Interests: cell therapy; cardiac repair; gene therapy; exosomes; omics; pulmonary hypertension; cardiotoxicity; heart failure
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Ischemic heart disease (IHD) and end-stage heart failure are major causes of morbidity and mortality, and millions of IHD patients are treated by various medications, bypass surgery, or angioplasty around the world. Although treatment for acute myocardial infarction has improved over the past decades, including early reperfusion of occluded coronary arteries, novel therapeutic strategies are required to preserve cardiac function and improve clinical outcomes in patients with IHD. Additionally, new therapies are needed for the increased burden of chronic stages of heart failure. Transplantation of stem/progenitor cells has been considered as an alternative treatment for heart repair in both the acute and chronic phases of the disease. Although several issues have been raised from recent findings that stem cell therapy does not–or not yet in its current form–lead to muscle regeneration, some benefits have been observed. In fact, after the modest successes of the early clinical trials, research is now exploring the benefits of enhanced cell-based therapy and therapies with cell products.
This Special Issue will highlight recent advances in the context of cell therapy for cardiovascular disease.
Prof. Dr. Rosalinda Madonna
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Cell therapy
- Cardiac repair
- Myocardial ischemia
- Mesenchymal stromal cells
- Pluripotent stem cells